Precision Medicine Using Pharmacogenomic Panel-Testing

Although drug treatment is often successful, adverse drug reactions (ADRs) and lack of efficacy present a significant burden for individual patients and society as a whole. ADRs are an important cause of emergency department visits and hospital admissions. A study in 2 large UK hospitals showed that 6.5% of hospital admissions were attributable to ADRs1. In the United States, ADR-related morbidity and mortality have been estimated at $30 billion to $136 billion annually2. In parallel, lack of efficacy also results in a significant burden.

Source: Clinics in Laboratory Medicine - November 9, 2022 Category: Laboratory Medicine Authors: Cathelijne H. van der Wouden, Henk-Jan Guchelaar, Jesse J. Swen Source Type: research